🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesGLP-1 and peripheral arterial disease — looking for input Page 7

GLP-1 and peripheral arterial disease — looking for input

dan_philly Thu, Mar 21, 2024 at 8:07 PM 44 replies 3,088 viewsPage 7 of 9
Dr.DermMIA
Member
456
2,123
May 2024
Miami, FL
Apr 9, 2024 at 4:25 AM#31
dan_philly said:
Cardiac biomarkers and cardiovascular risk: my cardiologist ordered advanced cardiac labs given my family history.

Mine went the same way, slower. The detail I would add is minor and it is already implied above.

Last edited: Apr 9, 2024 at 6:25 AM
19 17LipidDoc_ATL, BariatricNurseD, MASHdoc_SA and 16 others
Reply Quote Save Share Report
tom_AK
New Member
28
112
Jan 2026
Anchorage, AK
Apr 10, 2024 at 11:32 AM#32
dan_philly said:
Cardiac biomarkers and cardiovascular risk: my cardiologist ordered advanced cardiac labs given my family history.

Dizziness and cardiovascular risk: I was lightheaded for the first 3 weeks. Root cause was a combination of reduced caloric intake and mild dehydration.

Fix: minimum 80-100oz water daily, don't skip meals even if you're not hungry (eat small protein-rich snacks), and stand up slowly from sitting/lying positions. Also check your blood pressure — GLP-1-induced weight loss can make BP meds too strong, requiring dose reduction.

20 18VanRx_Mike, steve_okc, dave_SLC and 17 others
Reply Quote Save Share Report
kate.chem
VIP Member
3,890
17,654
Dec 2023
California
Apr 11, 2024 at 6:38 PM#33
dan_philly said:
Cardiac biomarkers and cardiovascular risk: my cardiologist ordered advanced cardiac labs given my family history.

CRP reduction on cardiovascular risk — this is the lab result that excites me most:

Baseline hsCRP: 6.0 mg/L (high cardiovascular risk)
Month 6 hsCRP: 2.5 mg/L (moderate risk)
Month 12 hsCRP: 0.4 mg/L (low risk)

This level of inflammatory marker reduction is comparable to what you'd see with statin therapy. Combined with the weight loss, my 10-year ASCVD risk score dropped from 13% to 5%. My cardiologist is genuinely impressed.

21 19tyler_CSCS, VanRx_Mike, steve_okc and 18 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
JessicaM_2024
Member
823
3,456
Mar 2024
Portland, OR
Apr 13, 2024 at 1:43 AM#34

One thing that is still open after dan_philly’s answer:

Did your prescriber agree with that reading, and if not what was their objection?

22 20Dr.PainCLE, mike_mealprep, NicoleRaleigh and 19 others
Reply Quote Save Share Report
tyler_CSCS
Member
567
2,567
Jun 2024
Phoenix, AZ
Apr 14, 2024 at 8:48 AM#35
kate.chem said:
CRP reduction on cardiovascular risk — this is the lab result that excites me most: Baseline hsCRP: 6.0 mg/L (high cardiovascular risk) Month 6 hsCRP:…

This is where I part company with the consensus forming above. I would resist the confidence. Half of what this board was certain about two years ago has since been quietly dropped, and nobody went back to correct the threads.

23 21bbq_ray_KC, oliver_london, tane_welly and 20 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register